Authors
Latest:
Addressing Dust Accumulation in Tablet ManufacturingDedusting equipment and techniques address problems associated with tablet manufacturing dust accumulation.
Latest:
Planning a Biologics Facility Start UpIntegrating quality and compliance with technology transfer and careful project management are key in starting up a facility and launching a biologic drug.
Latest:
Forced Degradation Studies for BiopharmaceuticalsThe author addresses critical issues to consider prior to performing forced degradation studies and provides best practice recommendations for these types of studies.
Latest:
Choosing Tableting Tooling for Compressing Abrasive FormulationsWear-resistant materials and coatings protect tablet punches and dies from abrasive formulations.
Latest:
Considerations for Tablet Compression with Multi-Tip ToolingThis article examines multi-tip tool technology for pharmaceutical tablet compression and the process control and validation issues that must be carefully evaluated to assess the potential for success.
Latest:
Meeting USP Guidelines for Elemental Impurity Analysis with X-ray Fluorescence SpectrometryThe author discusses how x-ray spectrometry can be an effective way to measure these impurities and meet regulatory guidelines.
Latest:
Regulatory Considerations for Controlling Intermediates in Type-II Drug Master Files for the Manufacture of Generic Drug SubstancesThe authors present analysis of the state of control of intermediate identity and quality, based on analysis of recently submitted DMFs.
Latest:
Regulatory Considerations for Controlling Intermediates in Type-II Drug Master Files for the Manufacture of Generic Drug SubstancesThe authors present analysis of the state of control of intermediate identity and quality, based on analysis of recently submitted DMFs.
Latest:
Regulatory Considerations for Controlling Intermediates in Type-II Drug Master Files for the Manufacture of Generic Drug SubstancesThe authors present analysis of the state of control of intermediate identity and quality, based on analysis of recently submitted DMFs.
Latest:
Regulatory Considerations for Controlling Intermediates in Type-II Drug Master Files for the Manufacture of Generic Drug SubstancesThe authors present analysis of the state of control of intermediate identity and quality, based on analysis of recently submitted DMFs.
Latest:
Appendix: Common Deficiencies Related to Solution NMR in the Type-II DMFsAppendix to Characterization of Small-Molecule Drug Substances in Type II DMFs Supporting ANDAs, Part I: Solution Nuclear Magnetic Resonance Spectroscopy
Latest:
Regulatory Considerations for Controlling Intermediates in Type-II Drug Master Files for the Manufacture of Generic Drug SubstancesThe authors present analysis of the state of control of intermediate identity and quality, based on analysis of recently submitted DMFs.
Latest:
FT-IR Identification: the Expertise Required To Ensure ComplianceBy providing an information "fingerprint", infrared red spectroscopy is a useful tool for identifying counterfeit pharmaceuticals. The authors identify best practices for ensuring compliance.
Latest:
Choosing Containment Strategies For Highly Potent APIsSafe handling of HPAPIs requires determining exposure potential and selecting appropriate containment strategies.
Latest:
Contamination: Invisible And AirborneMillions of pounds worth of products are at risk if contamination occurs in a cleanroom environment. According to an independent consultant (Cleanroom Management Associates Inc) for our company, contamination from personnel and equipment, such as wheeled carts and tanks, is a major concern in cleanrooms and controlled environments.
Latest:
Best Practice: Testing Softgel CapsulesTexture analyzers can be used to evaluate wall hardness and elasticity of softgel capsules.
Latest:
Best Practice: Testing Softgel CapsulesTexture analyzers can be used to evaluate wall hardness and elasticity of softgel capsules.
Latest:
Testing the Integrity of Lyophilized Product ContainersNon-destructive container closure integrity testing allows 100% inspection of all ampoules, syringes, vials, and cartridges.
Latest:
Updates on Container Closure Integrity Testing for Sterile InjectablesChanges in CCIT testing have followed the evolution of regulatory guidance, and this article examines different possible CCIT strategy approaches.
Latest:
Specimen Logistics: The Rx for a Better DxUsing best practices in specimen preparation, packaging, and shipping can improve efficiency for diagnostic laboratories.
Latest:
Concept Design for Establishing an Eco-Friendly Pharmaceutical Production Facility in MaltaThe authors discuss the concept design of a versatile, sustainable, small-scale facility in Malta that conforms to the European Union’s current good manufacturing practices.
Latest:
Concept Design for Establishing an Eco-Friendly Pharmaceutical Production Facility in MaltaThe authors discuss the concept design of a versatile, sustainable, small-scale facility in Malta that conforms to the European Union’s current good manufacturing practices.
Latest:
Concept Design for Establishing an Eco-Friendly Pharmaceutical Production Facility in MaltaThe authors discuss the concept design of a versatile, sustainable, small-scale facility in Malta that conforms to the European Union’s current good manufacturing practices.
Latest:
Concept Design for Establishing an Eco-Friendly Pharmaceutical Production Facility in MaltaThe authors discuss the concept design of a versatile, sustainable, small-scale facility in Malta that conforms to the European Union’s current good manufacturing practices.
Latest:
Best Practice: Choosing Glass Or Polymer For Parenteral PackagingConsider the 3 Ps (product, process, and patient) when choosing a parenteral packaging material.
Latest:
Controlled Crystallization During Freeze-DryingThe authors discuss the preparation of lipophilic drug nanocrystals by controlled crystallization during freeze-drying.
